Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report By Brand Type (Sativex, Epidiolex, Other Brands), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2024 - 2030

Market Segmentation

• Cannabis Pharmaceuticals Brand Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Sativex
  • Epidiolex
  • Other Brands
• Cannabis Pharmaceuticals Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • North America cannabis pharmaceuticals market, by Brand Type
      • Sativex
      • Epidiolex
      • Other Brands
    • U.S.
      • U.S. cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Canada
      • Canada cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
  • Europe
    • Europe cannabis pharmaceuticals market, by Brand Type
      • Sativex
      • Epidiolex
      • Other Brands
    • UK
      • UK cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Germany
      • Germany cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Italy
      • Italy cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • France
      • France cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Netherlands
      • Netherlands cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Poland
      • Poland cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Czech Republic
      • Czech Republic cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Switzerland
      • Switzerland cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Croatia
      • Croatia cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
  • Asia Pacific
    • Asia Pacific cannabis pharmaceuticals market, by Brand Type
      • Sativex
      • Epidiolex
      • Other Brands
    • Japan
      • Japan cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • South Korea
      • South Korea cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Australia
      • Australia cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • New Zealand
      • New Zealand cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
  • Latin America
    • Latin America cannabis pharmaceuticals market, by Brand Type
      • Sativex
      • Epidiolex
      • Other Brands
    • Brazil
      • Brazil cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Mexico
      • Mexico cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Argentina
      • Argentina cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Colombia
      • Colombia cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Uruguay
      • Uruguay cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Chile
      • Chile cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
    • Peru
      • Peru cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands
  • Middle East and Africa
    • Middle East and Africa cannabis pharmaceuticals market, by Brand Type
      • Sativex
      • Epidiolex
      • Other Brands
    • Israel
      • Israel cannabis pharmaceuticals market, by Brand Type
        • Sativex
        • Epidiolex
        • Other Brands

Cannabis Pharmaceuticals Market Dynamics

Driver: Growing Number of Clinical Trials

The rising number of clinical trials signifying the positive effects of utilizing cannabis pharmaceuticals for treating various medical conditions, such as multiple sclerosis, epilepsy, chronic pain, and cancer, is a major factor boosting market growth. Positive results provided by clinical trials help change the perspective of patients and healthcare professionals toward cannabis and pharmaceutical drugs developed using cannabis. For instance, as per the data provided by ClinicalTrials.gov, as of 2022, there are around 722 studies for Sativex that are active, either recruiting, not recruiting, or enrolling by invitation. In addition, around 401 clinical trials are active for Epidiolex under the same criteria.

Political & Legal Opportunities - 

• The market is expected to grow at a rapid pace in the coming years owing to the increasing number of research and clinical trials demonstrating the potential benefits of cannabis-based drugs on other medical conditions

• Increasing investments by key market participants in developing cannabis-based pharmaceutical products to cater to the rising demand for these drugs in the market

Economic & Social Opportunities -

• The launch of cannabis-based drugs in the market for treating specific medical conditions is expected to drive its demand

• Geographic expansion by companies through strategic initiatives, such as distribution agreements, is expected to create opportunities for market growth

Restraint: Presence of Stringent Regulations On Cannabidiol-Infused Products

In the last few years, cannabidiol has become immensely popular globally and is used to treat a wide range of lifestyle diseases & medical conditions, such as inflammation, sleep disorders, pain, schizophrenia, epilepsy, anorexia, symptoms of multiple sclerosis, & other conditions. In addition, there is a high demand for cannabidiol in cosmetic products, such as lotions, creams, & moisturizers, and food items & beverages. Despite the high demand and increasing availability of cannabidiol, there are several uncertainties pertaining to its safety, quality, & legality. In the European Union, seeds for planting are only to be purchased from certified providers to ensure that the right variety of hemp is cultivated, as hemp is a rich source of cannabidiol.

What Does This Report Include?

This section will provide insights into the contents included in this cannabis pharmaceuticals market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Cannabis pharmaceuticals market qualitative analysis

• Industry overview

• Industry trends

• Market drivers and restraints

• Market size

• Growth prospects

• Porter’s analysis

• PESTEL analysis

• Key market opportunities prioritized

• Competitive landscape

  • Company overview

  • Financial performance

  • Product benchmarking

  • Latest strategic developments

Cannabis pharmaceuticals market quantitative analysis

• Market size, estimates, and forecast from 2018 to 2030

• Market estimates and forecast for product segments up to 2030

• Regional market size and forecast for product segments up to 2030

• Market estimates and forecast for application segments up to 2030

• Regional market size and forecast for application segments up to 2030

• Company financial performance